ADAM 8 as a novel target for doxorubicin delivery to TNBC cells using magnetic thermosensitive liposomes.
Alawak M, Abu Dayyih A, Mahmoud G, Tariq I, Duse L, Goergen N, Engelhardt K, Reddy Pinnapireddy S, Jedelská J, Awak M, König AM, Brüßler J, Bartsch JW, Bakowsky U.
Alawak M, et al. Among authors: brussler j.
Eur J Pharm Biopharm. 2021 Jan;158:390-400. doi: 10.1016/j.ejpb.2020.12.012. Epub 2020 Dec 16.
Eur J Pharm Biopharm. 2021.
PMID: 33338603